A new simple, selective, linear and accurate chiral HPLC method for assay of carvedilol enantiomers was developed with immobilized cellulose chiral stationary phases under normal-phase mode using hexane:
INTRODUCTION
Chemically, carvedilol is ((±)-1-(carbazol-4yloxy)-3-[[2-(O-methoxy-phenoxy)ethyl]amino]-2propanol) ( Figure 1 ). It is administered as a enatiomeric mixture of the R(+)-and S(−)-isomers. These isomers possess vasodilation and β-blockage properties. 1 It is seen that only the S-enantiomer of carvedilol exerts β-blocking effects.
There are many methods for the enantioselective analysis of carvedilol which include derivatization with chiral reagents (indirect methods) or the use of chiral stationary phases (direct methods).
In indirect methods, it was reported to make chiral derivatization of carvedilol 2-6 by employing various reagents for analyzing of carvedilol by using RP-HPLC with UV or fluorescence detector, or liquid chromatography-tandem mass spectrometry (LC-MS/MS). 7 In direct methods chiral stationary phase columns and/or mobile phases containing chiral additives are used. [8] [9] [10] A chiral selector agent named as hydroxypropyl-beta-cyclodextrin has also been used in capillary electrophoresis for the enantioselective analysis of carvedilol in serum. 11, 12 Now a days, direct chiral separations are being carried out by using chiral stationary phases (CSPs). 13 Separation of enatiomeric compounds by HPLC is more versatile than GC because GC can separate volatile compounds. However, HPLC with appropriate detection devices can provide fast and accurately the mass and optical rotation of enantiomers as well as quantify them by chiral separation. 14, 15 In this study, separation of carvedilol enantiomers was accomplished by a new commercial CSP based upon cellulose tris-(3,5dichlorophenylcarbamate) polymer immobilized on silica. Cellulose and amylose derived chiral stationary phase in the chiral columns are extensively applicable to separate enantiomers with good capability. [16] [17] [18] [19] [20] [21] [22] The objective of the present research work was to develop a rapid, simple and reproducible direct HPLC method for the analysis of enantiomeric compounds of carvedilol. 
Carvedilol

MATERIALS AND METHODS
Materials.
The standard of carvedilol (>98%) was a kind gift from Incepta Pharmaceuticals Ltd., Dhaka, Bangladesh. S-carvedilol, HPLC grade hexane, isopropyl alcohol, diethyl amine and acetic acid were purchased from Sigma-Aldrich, Germany. Before analysis, all the solutions and solvents were filtered through 0.45 µm membrane filter tips.
Instruments and chromatographic conditions.
HPLC was performed on Prominence HPLC (SIL 20 series, Shimadzu, Japan). The instrument was equipped with an auto sampler (Model SIL-20 AC), dual pumps (Model 20 AD), column oven (Model CTO-20A), vacuum degasser (Model DGU-20A), UV-visible detector (Model SPD-20A). Chromatographic separation was carried out on Chiralpak IC column (4.6 x 250 mm, Chiral Technologies, Daicel group, Tokyo, Japan). The elution was performed with polar mobile phase of hexane: isopropyl alcohol: diethyl amine: acetic acid (40: 60: 0.7: 0.3, v/v) at a flow rate of 1.0 mL/min and detection was performed at 220 nm.
Standard solutions.
Stock standard solutions of concentration of 200 µg/ml of carvedilol were prepared by dissolving 20 mg powder in the mixture of hexane and isopropanol (1:1 v/v) and by adjusting the final volume to 100 ml in a 100 ml volumetric flask. Further dilutions of the stock solutions of carvedilol with appropriate volumes of diluent were carried out to obtain solutions of concentrations of 30, 60, 80, 100, and 130 μg/ml. S-carvedilol standard solution was also prepared and analyzed to confirm the enantiomers of carvedilol.
Sample solutions of carvedilol. Twenty tablets were collected from each 5 companies. Powdersamples equivalent to 5 mg of each brand were transferred to a 50 ml volumetric flask. The content was dissolved with suitable volume of diluents followed by adjusting the final volume up to the mark with diluents. After preparation the samples were analyzed immediately.
Method validation
Specificity of the method was done by analyzing standard compounds to observe any potential interference. System suitability tests were performed to check the resolution and reproducibility of the chromatographic method. The calibration curves were obtained by plotting the peak area of each enantiomer against the respective concentration and the linearity was evaluated by calculating the regression coefficient values of the curves. The stability of the standard and sample solutions was also checked under normal conditions, normal storage conditions, and sometimes in the special instrument conditions. Accuracy, precisions (intraday and inter-day), LOD and LOQ of the method were carried out according to USP and ICH guidelines. 23 Robustness of the new method was also checked by changing the chromatographic parameters, like flow rate and wavelength.
Stability test.
To study the measuring ability of active ingredient and its degradation products by the new method, the drug was exposed to heat, light, acid, base, and oxidizing agents followed by analysis using the method. The stability tests were carried out under stress conditions including acid hydrolysis (0.1 N HCl at 60 o C), basic hydrolysis (0.1 N NaOH at 60 o C), peroxide degradation (3% H 2 O 2 at 60 o C), thermal degradation (60 o C) and photolysis (at 220 nm) for consecutive five days (1 st , 3 rd and 5 th days). The drug solutions with concentration of 50 μg/mL were prepared in methanol for acid, basic and peroxide, where as samples were prepared with diluent at a concentration of 50 μg/ml for thermal and photolysis degradations. All the resultant solutions were analyzed thrice by the new developed method.
RESULTS AND DISCUSSION
Method development. In order to analysis of carvedilol enantiomers by a fast and easy chiral HPLC technique we tried to develop a new method using a large number of polar and non-polar solvent mixtures as mobile phase which is shown in table 1.
Ultimately a suitable chromatographic conditions was achieved with chiralpak IC and n-hexane: isopropylalcohol: diethylamine: acetic acid (40: 60: 0.7: 0.3, v/v) as mobile phase due to good resolution with symmetrical peak shape and acceptable theoretical plates number.
Comparison of the present work. The newly developed and validated method was found to be better than previously reported methods for analyzing enantioresolution of carvedilol which is shown in table 2. It clearly established the novelty and superiority of the new method in terms of resolution. Finally, this present method has been extensively validated according to the following parameters.
Validation of the proposed method. 23
Linearity and range. Linearity of the method was achieved by triplicate injection of five concentrations of each two enantiomers of carvedilol in concentration range of 30-130 µg/ml. To obtain the calibration curves corresponding peak areas were plotted against concentrations ( figure 2, table 3 ).
Precision. Intraday and inter-day precisions were studied by injecting six replicates of one concentration on same day and on three different days, respectively. Results are shown in table 3.
Accuracy. Accuracy was determined by successive analysis (n=3) of standard solutions with spiking of the drug and the results are shown in table 4. Specificity. The specificity of the method for carvedilol and S-carvedilol was achieved without any interference as shown in figure 3. System suitability. Retention factor (k), enantioseparation factor (α), and resolution (R) for system suitability were determined using the following equations: k = (t−t 0 )/t 0 , where t and t 0 are the retention times of carvedilol and unretained solutes, respectively; α = k R /k S , where k S and k R are the retention factors of (S)-and (R)-enantiomer of carvedilol, respectively; R = 2(t R −t S )/(w R +w S ), where t S and t R are retention times of the (S)-and (R)enantiomers, respectively, and w S and w R are the baseline peak widths of the two enantiomers. The parameters of system suitability tests are given in table 5.
Limit of detection (LOD) and limit of quantification (LOQ). LOD and LOQ were obtained
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Solution stability. Table 6 shows the results of solution stability tests which were obtained after keeping pure drug solutions (60 µg/ml) in tightly capped volumetric flask at room temperature (25 o C) and at 4 o C for 3 days.
Robustness of the method. The robustness for the developed method, flow rate and wavelength were changed a minor range i.e. (1.0 ± 0.2 ml/min), (220 ± 2nm), respectively. The results of the robustness wer expressed in % RSD and are shown in table 7. All peaks of the carvedilol were remaining unchanged.
Stability test. The drug was exposed to acid, alkali, oxidative, photolysis and thermal stress conditions for five days and on 1 st , 3 rd , and 5 th days, aliquot of the samples were analyzed to check the degradation. In photolysis, carvedilol was completely degraded and in other conditions it remained almost stable. The stability tests results are shown in table 8.
Application of the method. The new method was used to analyze carvedilol in pharmaceutical preparation and also to determine the enantiomeric purity of the samples. Results of enantiomeric purity of five commercial samples are shown in figure 4 and table 8. 
CONCLUSION
A sensitive, simple, and accurate method for enantioseparation of carvedilol enantiomers was developed by chiralpak IC column. The method provided good enantioseparation factor (α = 3.26) and resolution (R = 7.9) with the mobile phase of hexane-isopropyl alcohol-diethyl amine-acetic acid (40: 60: 0.7: 0.3, v/v).
By this method (S)-and (R)-carvedilol were identified rapidly by a single analysis (approximately within 17 min). This method was also validated properly and it was found that the method was simple, fast, accurate, repeatable and precise. Therefore, the method can be used for the routine analysis of carvedilol enantiomers in pharmaceutical formulations.
